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Partitioning the transcriptional program induced by rapamycin
among the effectors of the Tor proteins
Alykhan F. Shamji, Finny G. Kuruvilla and Stuart L. Schreiber
Background: In all organisms, nutrients are primary regulators of signaling
pathways that control transcription. In Saccharomyces cerevisiae, the Tor
proteins regulate the transcription of genes sensitive to the quality of available
nitrogen and carbon sources. Formation of a ternary complex of the
immunosuppressant rapamycin, its immunophilin receptor Fpr1p and Tor1p or
Tor2p results in the nuclear import of several nutrient- and stress-responsive
transcription factors.
Results: We show that treating yeast cells with rapamycin results in a broader
modulation of functionally related gene sets than previously understood. Using
chemical epistasis and vector-based global expression analyses, we partition
the transcriptional program induced by rapamycin among five effectors
(TAP42, MKS1, URE2, GLN3, GAT1) of the Tor proteins, and identify how the
quality of carbon and nitrogen sources impinge upon components of the
program. Biochemical data measuring Ure2p phosphorylation coupled with the
partition analysis indicate that there are distinct signaling branches
downstream of the Tor proteins.
Conclusions: Whole-genome transcription profiling reveals a striking
similarity between shifting to low-quality carbon or nitrogen sources and
treatment with rapamycin. These data suggest that the Tor proteins are
central sensors of the quality of carbon and nitrogen sources. Depending on
which nutrient is limited in quality, the Tor proteins can modulate a given
pathway differentially. Integrating the partition analysis of the transcriptional
program of rapamycin with the biochemical data, we propose a novel
architecture of Tor protein signaling and of the nutrient-response network,
including the identification of carbon discrimination and nitrogen
discrimination pathways.
Background
The Tor proteins are members of the phosphatidylinositol
kinase (PIK)-related kinases which have critical roles in
the sensing and response to cellular stress (for review see
[1]). They are key components of nutrient signaling in
the budding yeast Saccharomyces cerevisiae. The Tor pro-
teins have a mammalian ortholog, FRAP, also known as
RAFT or mTOR, that has been shown to be responsive to
the presence of amino acids [2]. Other mammalian PIK-
related kinases include ATM, ATR, and DNA-PK, which
sense and respond to DNA damage by controlling proteins
such as p53.
Bacteria exploit the centrality of Tor proteins in yeast
nutrient signaling to wage microbiological warfare. Strepto-
myces hygroscopicus secretes the compound rapamycin,
which forms a ternary complex with the yeast proteins
immunophilin FKBP12 (Fpr1p) and Tor1p or Tor2p [3–5].
Complexing the Tor proteins with Fpr1p–rapamycin
causes yeast to enter a state that resembles starvation, a
phenotype that includes translational downregulation and
cell-cycle arrest [6], thereby reducing their competition
with the bacteria for nutrients. By forming a ternary
FKBP12–rapamycin–FRAP complex, rapamycin also causes
mammalian cells to enter a starvation state and arrest,
which is the reason for its success as an immunosuppres-
sant (Rapamune). The Tor proteins are likely to exist in
two distinct states in vivo, a ‘nutrient state’ when nutrients
are abundant and a ternary complex-like state (referred
to as the ‘ternary complex state’) when nutrients are
scarce. The ternary complex state that is induced by
Fpr1p–rapamycin or lack of nutrients does not represent
inhibition of kinase activity, but probably an alteration of
substrate specificity [7].
Global transcription profiling studies of yeast treated with
rapamycin uncovered the primary nutrient signaling path-
ways controlled by the Tor proteins [8,9]. It was found that
these proteins control pathways responding to the quality
of available carbon and nitrogen sources [8]. Treatment
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with rapamycin causes cells to appear as if they are
glucose-deprived, with concomitant downregulation of
hexose transporter gene transcription and upregulation of
genes involved in respiration [8]. The Tor proteins also
regulate the nitrogen discrimination pathway (NDP, also
known as nitrogen catabolite repression or NCR) [8,9].
This results in the transcription of genes required for the
import and metabolism of low-quality nitrogen sources
such as proline or urea in the absence of high-quality nitro-
gen sources such as ammonia or glutamine [10,11].
The central effector of the NDP is Gln3p, a GATA-type
zinc-finger transcription factor that is repressed in the
presence of high-quality nitrogen sources by Ure2p, a
cytoplasmic anchor protein with homology to glu-
tathione-S-transferase [12,13]. Both Gln3p and Ure2p
normally reside as a complex in the cytoplasm [14]. Gln3p
is dephosphorylated upon treatment with rapamycin, disso-
ciates from Ure2p, and translocates into the nucleus to
activate transcription [14]. A second NDP transcription
factor, Gat1p, also translocates into the nucleus upon
rapamycin treatment [14]. Ure2p is also regulated by the
Tor proteins and is dephosphorylated following treat-
ment with rapamycin [8,9]. Why or how this coordinate
regulation of Gln3p, Gat1p and Ure2p occurs is not
understood, although these proteins have all been shown
to bind to the Tor proteins [15]. Mks1p, a protein down-
stream of Ras–cAMP, is also thought to signal nitrogen
quality to Ure2p [16,17].
Consistent with the fact that treatment with rapamycin
mimics low-quality carbon sources [8], the transcription
factors Rtg1/3p are translocated into the nucleus upon
rapamycin treatment to promote early tricarboxylic acid
(TCA) cycle gene transcription [18]. The Tor proteins also
regulate the translocation of the carbon-sensitive tran-
scription factors Msn2/4p by regulating their dissociation
from their 14-3-3 anchor proteins [14,19].
The phosphatase regulatory subunit Tap42p plays an
important role in signaling from the Tor proteins by con-
trolling translation and growth [20]. Upon treatment with
rapamycin, Tap42p dissociates from, and thereby dere-
presses, cellular phosphatases [20,21]. The dephosphory-
lation of Gln3p and Gat1p caused by complexing the Tor
proteins with FKBP12 (Fpr1p)–rapamycin is dependent
on Tap42p as it is not induced by rapamycin in strains har-
boring the rapamycin-resistant tap42-11 allele [14].
Although the transcription factors and phosphatase subunits
described above are known to be modulated by treatment
with rapamycin, little is known about their place in the sig-
naling architecture downstream of the Tor proteins. We
sought to determine the roles of these effectors in mediat-
ing the transcriptional program induced by rapamycin.
Results and discussion
We systematically analyzed the profile of yeast cells
treated with rapamycin to first define the transcriptional
program of the Tor proteins. The experiments were per-
formed in three different wild-type, haploid strains of
S. cerevisiae to confirm the relevance of the observations.
The profile of yeast treated with rapamycin for 30 minutes
reveals a strong transcriptional response aimed at inhibit-
ing translation on multiple levels by repressing ribosomal
protein synthesis [22], rRNA synthesis/processing, RNA
polymerase (Pol) I and RNA Pol III (but not Pol II) activ-
ity, translation initiation/elongation, tRNA processing/syn-
thetase production, and mRNA export/decay (Figure 1).
Whereas treatment with rapamycin specifically represses
Figure 1
The transcriptional phenotype of yeast cells
treated with rapamycin. Genes were grouped
by function based on their Munich Information
Center for Protein Sequences (MIPS)
designation [29], and the fold-induction of
each gene in a given group was graphed in a
horizontal point plot. The actual induction
values and the gene sets are publicly available
at http://www-schreiber.chem.harvard.edu.
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genes encoding cytoplasmic ribosomal proteins and tRNA
synthetases, mitochondrial ribosomal proteins and tRNA
synthetases are upregulated (Figure 1), a phenomenon
also observed when cells are depleted of glucose [23].
Other basic cell processes besides translation are regulated
transcriptionally. These include DNA replication, protein
degradation, respiration, storage carbohydrate synthesis,
hexose transport and nitrogen discrimination (Figure 1).
These transcriptional effects may contribute to the ability
of rapamycin to regulate storage carbohydrate synthesis,
translation and Pol I/III activity [6,24].
We examined how each of the processes described
above was modulated following the shift from high- to
low-quality nitrogen or carbon sources (glutamine versus
proline or glucose versus ethanol). We also compared
this to the previously published profile of the diauxic
shift [23]. This was done quantitatively by treating the
list of gene inductions for a given profile as an n-dimen-
sional vector (where n = the number of genes consid-
ered, up to ~6000) and finding the angle between any
two vectors and the ratio of their magnitudes (experi-
mental divided by reference). Calculation of both vector
angle and ratio of vector magnitudes is necessary for
analysis as angle is a measure of induction pattern simi-
larity (that is, if the same genes are being repressed or
activated) whereas ratio of vector magnitudes is a
measure of the induction strength similarity (that is,
given two profiles, how strongly are the same genes
affected). All results are depicted in a colorimetric com-
parison array (CCA) where the numerical value of a
comparison between two vectors (angle or ratio of mag-
nitudes) is expressed as a color (Figure 2).
We performed this comparative analysis using the con-
stant reference of a wild-type strain grown in a rich
medium treated with 50 nM rapamycin for 30 minutes.
This profile was compared to the same wild-type strain
shifted from high- to low-quality nitrogen or carbon
sources, to mutant strains (as well as their parent strains)
treated with rapamycin, where the mutations are in genes
encoding known or suspected effectors of the Tor pro-
teins, or to steady-state profiles of these mutant strains
versus their parental wild-type strains. Our primary goal
was to find effector genes that are epistatic to rapamycin
with respect to an aspect of its transcription profile
described above. In this ‘chemical epistasis’ analysis, the
upstream modulation is due to the actions of a small mole-
cule on a protein, rather than a gene mutation.
The angle CCA (Figure 2a) contains many red spots
(small angle) as many of the profiles are treatments with
rapamycin and thus share many similarities with the ref-
erence profile. Mutant steady-state profiles stripe the
CCA with columns of nearly yellow spots (angle near 90°)
as their profiles are very different from the transition
elicited by treatment with rapamycin. The ratio of vector
magnitudes CCA (Figure 2b) contains many green spots
(decreased magnitude). This is because treatment with
rapamycin is a very active profile with a large number of
genes being highly induced or repressed. Mutations in
effectors of the Tor proteins often blunt these high
inductions (even though they do not reverse their direc-
tions and hence preserve angle), resulting in a large
number of green spots in the CCA of vector magnitude
ratios. Occasionally, mutations in effectors of the Tor pro-
teins make classes of genes hypersensitive to rapamycin
(that is, give a greater vector magnitude than wild type, a
red spot) as is the case with a ure2∆ strain and ribosomal
protein expression (Figure 2b).
Both the transcription profiles of yeast cells shifted from
glutamine to proline and from glucose to ethanol strongly
correlate with the transcription profile of treatment with
rapamycin (whole-genome vector angles of 44° and 47°,
respectively, and whole-genome ratios of vector magni-
tudes of 0.72 and 1.11, respectively). The rapamycin
profile did not correlate with profiles of heat shock or
DNA damage induced by methyl methanesulfonate
(MMS) (whole-genome vector angles of 82° and 74°,
respectively). Many groups of genes, including NDP
target genes, behave similarly after shift to low-quality
nitrogen or carbon, or after treatment with rapamycin
(Figure 2a). These genome-wide comparisons indicate
that shifts to low-quality carbon or nitrogen sources elicit
very similar cellular transitions that are mimicked by the
formation of the Fpr1p–rapamycin–Tor ternary complex.
Similar comparisons were made between the profile of
rapamycin in wild-type strains and in strains mutated in
effectors of the Tor proteins (Figure 2a). The analysis
identifies Tap42p, a phosphatase regulatory subunit, as a
central effector of Tor-mediated transcription. By per-
forming the rapamycin profile of strains harboring the
tap42-11 allele, which renders cells resistant to
rapamycin-induced growth arrest [20], Gln3p dephospho-
rylation [14] and activation of the NDP [15], we were
able to partition rapamycin-sensitive transcription into
subsets with varying degrees of dependence on Tap42p
(Figures 2,3a). The fact that regulation of translation
factors, ribosomal proteins, rRNA processing genes and
ribosomal biogenesis genes depend on Tap42p
(Figure 3a) is consistent with the finding that Tap42p
controls protein synthesis [20]. The regulation of TCA
cycle genes, NDP target genes, storage carbohydrate
enzymes, purine biosynthesis and several other functional
groups also depends on Tap42p (Figure 3a). A smaller
subset, including genes encoding proteins for ATP syn-
thesis, proteasome subunits and mRNA export/decay is
regulated largely independently of Tap42p (Figure 3a).
Therefore, Tap42p is the central but not exclusive medi-
ator of rapamycin-sensitive transcription.
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It has recently been shown that rapamycin induces dephos-
phorylation of the cytoplasmic anchor protein Ure2p [8,9]
and its target transcription factor Gln3p [14]. Although
Gln3p dephosphorylation does not occur in a tap42-11 strain
[14], rapamycin-induced dephosphorylation of Ure2p still
occurs in a tap42-11 strain, implying that its dephosphoryla-
tion is not regulated by Tap42p (Figure 3b). Thus, the Tor
proteins regulate the Ure2p–Gln3p transcription complex
through at least two distinct pathways.
NDP target genes are activated by the GATA-type tran-
scription factors Gln3p and Gat1p [11]. As a group, the
ratios of vector magnitudes for NDP genes after treat-
ment with rapamycin for a gln3∆ or gat1∆ strain (refer-
enced to a wild-type strain treated with rapamycin) are
0.45 and 0.43-fold (Figure 2b), indicating that removal of
either effector significantly dampens induction of NDP
target genes. Deleting URE2 is sufficient to activate all
NDP target genes, but subsequent deletion of GLN3
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The colorimetric comparison array (CCA) for the vector angles between
the rapamycin profile and 19 other profiles. The numerical values used
in the CCAs as well as the computer code from which the values were
calculated are publicly available for download (http://www-
schreiber.chem.harvard.edu). There is a continuum of color between red
and green and a numerical value is linearly interpolated between the
boundaries to select a particular RGB color value. All depicted profiles
were generated in this study except for the profiles of the diauxic shift
[23], heat shock [30] and treatment with MMS [31]. (a) In the vector
angle CCA, red signifies a correlation with similar directions
(0° < angle < 90°), yellow signifies no correlation with orthogonality
(angle = 90°), and green signifies an anticorrelation with opposing
directions (90° < angle < 180°). Each of the columns represents a
comparison between the reference profile of the wild-type 1 (wt1) strain
in YPD versus the same strain treated with 50 nM rapamycin in YPD for
30 min and the profile specified by the column title (wt1 strain, PM38;
wt2 strain, Jk9-3d; wt3 strain, YHE711). The first row is a comparison of
two vectors of up to ~6000 dimensions, representing the whole-
genome profiles. Successive rows are comparisons of two vectors of
lower dimensions, representing subsets of genes grouped by function.
The profiles in the CCA are: glutamine vs proline, the wt1 strain shifted
from synthetic glucose medium with glutamine (SD-Q) to SD-Q medium
for 30 min compared to a shift to synthetic glucose medium with proline
for 30 min; glucose vs ethanol, the wt1 strain shifted from SD-
ammonium sulfate (AS) medium to SD-AS medium for 30 min
compared to a shift to synthetic ethanol with AS medium for 30 min; nt,
not treated; strain vs strain + Rap indicates the strain in YPD with no
treatment versus the strain treated with 50 nM rapamycin in YPD for
30 min; wt vs strain, a wild type parent versus a mutant strain under
steady state conditions in YPD. (b) The CCA for the ratio of vector
magnitudes between the wt1 versus wt1 + rapamycin profile and the
same 19 profiles. In the ratio of vector magnitudes CCA, red signifies
greater magnitude (ratio > 1), yellow signifies unchanged magnitude
(ratio = 1) and green signifies decreased magnitude (ratio < 1).
abrogates expression of only a subset of these genes [25].
We performed this epistasis experiment on the global
level by comparing the steady-state transcription profiles
of ure2∆ and ure2∆ gln3∆ strains and hence isolating the
subset of the NDP target genes that are largely Gln3p-
independent, which includes PUT1, PUT2, UGA1, GAT1
and PRB1 (Figure 4a).
As mentioned, shifting cells from a fermentable (glucose)
to non-fermentable (ethanol) carbon source surprisingly
activates NDP target genes (Figure 2a,4b). The pattern of
induction of NDP target genes following the shift from
fermentable to non-fermentable carbon differs from the
pattern of induction following the shift from a high- to
low-quality nitrogen source (Figure 4b). Interestingly, four
of the five genes with the highest glucose-to-ethanol over
glutamine-to-proline induction ratio are among the subset
of genes identified as largely Gln3p-independent through
steady-state analysis (Figure 4b). These data suggest the
existence of a carbon discrimination pathway (CDP)
which can induce a subset of genes known to be under
control of the NDP (or the NCR pathway). Further sup-
porting the distinct NDP and CDP induction patterns is
the fact that in the diauxic shift, PUT1, UGA1, GAT1 and
PRB1 are induced, whereas other genes are generally
repressed or unchanged [23]. Our data suggest that
GATA-type transcription factors (Gln3p, Gat1p) will con-
tribute differently to NDP/CDP transcription depending
on the precise nutrient input signal. Interestingly, PUT1
and PRB1 show greater dependence on Gat1p than Gln3p
with respect to upregulation following treatment with
rapamycin (see Supplementary material). The ability of a
small molecule to modulate protein function instanta-
neously thus reveals both the primary and overlapping
functions of these GATA-type transcription factors.
In the presence of a low-quality nitrogen source, Mks1p is
thought to inhibit Ure2p, thereby allowing Gln3p to acti-
vate transcription of NDP target genes [17]. Treating mks1∆
or its parent strain with rapamycin revealed that NDP target
genes are induced in both strains, suggesting that the Tor
proteins may not signal through Mks1p. However, the
genes with low Gln3p-dependence as determined by
steady-state analysis have slightly elevated induction by
rapamycin in the mks1∆ strain whereas those with high
Gln3p-dependence have mildly dampened expression in
the mks1∆ strain (Figure 5a). Whether these effects reflect a
direct connection between the Tor proteins and Mks1p or
reflect parallel pathways is unclear. The rapamycin-induced
dephosphorylation of Ure2p also occurs in the mks1∆ strain
(Figure 5b), consistent with a model in which the Tor pro-
teins control Ure2p phosphorylation independently of
Mks1p. Surprisingly, however, deleting MKS1 abrogates
the rapamycin-induced expression of genes controlled by
the Rtg1/3p transcription complex, such as CIT2 and DLD3
([26], and Figure 5c). Treatment with rapamycin causes
Rtg1/3p to translocate to the nucleus [18]; these data impli-
cate Mks1p in the control of their translocation.
Treatment with rapamycin activates transcription of
nearly all components of the TCA cycle [8]. Early TCA
cycle genes that can be used for glutamate production,
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Figure 3
Partitioning rapamycin-sensitive transcription
relative to Tap42p. (a) The geometric mean of
induction by rapamycin of each group of
genes depicted in Figure 1 was calculated for
the tap42-11 strain and its otherwise isogenic
parent. The groups of genes are listed in
order of ascending ratio of vector magnitudes
(tap42-11 divided by wild type). This ratio was
used to classify the groups into subsets with
high, medium and low dependence on
Tap42p. (b) Rapamycin-induced
dephosphorylation of Ure2p occurs in a strain
harboring the rapamycin-resistant tap42-11
allele. After treating wild-type cells (Jk9-3d)
and tap42-11 cells (TS19-4c) with 50 nM
rapamycin for 30 min, cells were lysed and the
protein lysates were western blotted using
anti-Ure2p antibodies.
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including CIT1, ACO1 and IDH1/2, are under the dual
control of Rtg1/3p and Hap2/3/4/5p [27]. Late TCA cycle
genes such as KGD1, SDH1 and MDH1 are exclusively
under the control of the Hap complex [27]. In respiration-
competent cells, the Hap complex induces transcription
of the early TCA cycle genes, whereas in respiration-defi-
cient cells, control of these genes switches to Rtg1/3p
[27]. Mks1p has been shown to repress early TCA cycle
activity [28]. Rapamycin fully activates late TCA cycle
genes and partially activates early TCA cycle genes
(except CIT1) in an mks1∆ strain (Figure 5c). This is con-
sistent with a model in which treatment with rapamycin
activates both Rtg1/3p and the Hap complex and where
activation of Rtg1/3p only occurs through Mks1p. The
subset of rapamycin-sensitive genes regulated by Mks1p
is a subset of the genes controlled by Tap42p, suggesting
that the Tor proteins signal to Mks1p through Tap42p.
The transcription profiles of rapamycin in strains mutated
for effectors of the Tor proteins reveal the architecture of
the regulatory network that mediates rapamycin-sensitive
transcription (Figure 6). The analysis was performed by
dividing the transcriptional program induced by a small
molecule into a list of induced and repressed gene sets,
and by noting how these gene sets behave after deleting
different effectors of the protein targeted by the small
molecule. This method of network analysis involving the
logic of epistasis and the instantaneous modulation of
function with a small molecule allows determination of
whether a particular effector controls a particular process.
Materials and methods
Strains, media and reagents
The following S. cerevisiae strains were used in this study. Strains
PM38 (MATα leu2-3,112 ura3-52), PH2 (MATα leu2-3,112 ura3-52
ure2∆12::URA3), PM71 (MATα leu2-3,112 ura3-52 gln3∆5::LEU2),
P40-1A (MATα leu2-3,112 his4-619 ade2-102 gln3∆4::LEU2
ure2∆11::LEU2), and MS221 (MATα ura3-52 nil1::hisG) were kind
gifts from Boris Magasanik and Marjorie Brandriss. Strains Jk9-3da
(MATa leu2-3,112 ura3-52 trp1 his4 rme1 HMLα) and TS19-4c (Jk9-
3da tap42::kanMX/YCplac111::tap42-11ts) were kindly provided by
Michael Hall. Strains YHE711 (MATα ura2 leu2∆::hisG) and YHE710
(MATα ura2 leu2∆::hisG mks1∆::G418) were generously provided by
Reed Wickner. YPD consists of 20 g glucose/l, 20 g peptone/l, and
10 g yeast extract/l. Synthetic media consist of 0.17% yeast nitrogen
base without amino acids or ammonium sulfate, 2% carbon source
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Figure 4
Two patterns of NDP target gene induction. (a) Comparison of the
steady-state transcription profiles of a ure2∆ strain (PH2) and a ure2∆
gln3∆ strain (P40-1A) partitions NDP target genes into two subsets
with either high or low Gln3p-dependence for induction. The DAL
genes were not included as their inductions were potentiated in a
ure2∆ gln3∆ strain. (b) The induction of NDP target genes following a
shift from glutamine to proline (Q→P) and glucose to ethanol (G→E).
The genes are listed in order of increasing G→E to Q→P induction
ratio, and the genes identified as having low Gln3p-dependence in
Figure 4a are listed in bold.
Gln3p-
dependence
Gene wt vs
ure2∆
wt vs
ure2∆ gln3∆
Gene Glutamine to
proline
Glucose to
ethanol
Ratio
(G      E /Q      P)
Current Biology   
(a)
(b)
GLN1 +8.2 +1.0
GAP1 +26.0 +7.7
CPS1 +8.5 +1.9High
GDH2 +8.1 +1.0
AGP1 +6.4 -1.4
PUT1 +29.4 +27.3
PUT2 +5.7 +5.0
GAT1 +5.2 +4.6Low
PRB1 +2.8 +2.0
UGA1 +4.1 +2.7
GLN1 +1.0 0.1
DAL3 +16.2
+9.1
+2.1 0.1
DAL7 +13.2 +2.6 0.2
GAP1 +13.7 +3.3 0.2
DAL4 +14.1 +3.5 0.2
PUT2 +11.2 +2.7 0.2
DAL1 +6.4 +1.7 0.3
CAR1 +9.6 +2.6 0.3
UGA4 +7.7 +2.2 0.3
DAL5 +19.5 +5.6 0.3
DAL2 +9.5 +3.1 0.3
AGP1 +4.9 +1.8 0.4
CPS1 +3.9 +1.5 0.4
DUR1,2 +2.7 +1.1 0.4
DAL80 +17 +7.6 0.5
PRB1 +4.9 +2.6 0.5
PUT1 +20.7 +11.5 0.6
GAT1 +3.4 +2.3 0.7
UGA1 +5.8 +4.7 0.8
GDH2 +4.7 +4.3 0.9
Figure 5
Mks1p as an effector of the Tor proteins. (a) The induction of two
subsets of NDP target genes are mildly and differentially affected by
rapamycin in an mks1∆ strain. (b) Rapamycin-induced
dephosphorylation of Ure2p occurs in an mks1∆ strain. After treating
wild-type cells (YHE711) and mks1∆ cells (YHE710) with 50 nM
rapamycin for 1 h, cells were lysed and the protein lysates were
western blotted using anti-Ure2p antibodies. (c) TCA cycle genes
are grouped by their transcriptional activators in order to examine the
effect of deleting MKS1 on their expression. Mks1p controls
Rtg1/3p-mediated but not Hap2/3/4/5p-mediated transcription.
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(a)
(b)
(c)
Gln3p-
dependence
Gene wt vs
wt + Rap
mks1∆ vs
mks1∆  + Rap
GLN1 +3.4 +1.3
GAP1 +16.9 +11.4
CPS1 +6.6 +5.5High
GDH2 +2.6 +1.7
AGP1 +3.1 +3.2
PUT1 +7.3 +9.6
PUT2 +4.9 +5.5
GAT1 +3.5 +4.5Low
PRB1 +4.2 +4.8
UGA1 +10.3 +10.3
Transcription
factor
Gene wt vs
wt + Rap
mks1∆ vs
mks1∆  + Rap
CIT2 +7.1 +1.0Rtg1/3p DLD3 +6.4 –1.2
KGD1 +2.5 +2.7
Hap2/3/4/5p SDH1 +5.1 +5.0
MDH1 +2.9 +3.6
CIT1 +5.8 +5.3
Rtg1/3p ACO1 +4.5 +2.1
Hap2/3/4/5p IDH1 +2.9 +1.2
IDH2 +5.2 +2.9
Rap
wt mks1∆
– + – +
Ure2p
(w/v if glucose or v/v if ethanol), and 0.1% of ammonium sulfate, gluta-
mine or proline as the nitrogen source. Auxotrophic supplements of
leucine (120 mg/l) and uracil (20 mg/l) were provided as needed.
Electrophoresis and western blotting
Anti-Ure2p immunoblots were prepared as described previously [8]
using antibodies generously provided by Reed Wickner.
Transcription profiling
Transcription profiling experiments were performed as previously pub-
lished [8] using cDNA competitive hybridization on glass slides. For
nutrient shift experiments, cultures of each strain were grown to
OD600 = 1, pelleted and washed with PBS, and resuspended in the rel-
evant media to the original cell density. The cultures were allowed to
grow for 30 min before harvest. All strains were grown at 30°C except
for the temperature-sensitive tap42-11 strain, TS19-4c, and its wild-
type parent, which were grown at the permissive temperature of 24°C.
Supplementary material
Supplementary material including complete transcription profiling data
sets and computer source code is available at http://current-biology.com/
supmat/supmatin.htm and http://www-schreiber.chem.harvard.edu.
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Figure 6
A model for how the Tor proteins communicate with transcription
factors as part of the nutrient-response network. The transcription
factors Gln3p and Gat1p contribute to the nitrogen discrimination
pathway (NDP) and the carbon discrimination pathway (CDP),
respectively, although there is overlap in their function. The Tor proteins
also signal to Msn2/4p as treatment with rapamycin results in their
nuclear translocation [14]. Despite the apparent symmetry in the figure,
low-quality nitrogen and carbon sources use the arms emanating from
the multichannel processing Tor proteins to varying degrees (see text).
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